Form 4 for IRON Disc Medicine, Inc.
Accepted 2023-12-29 00:00:00 ET · period of report 2023-12-27 · accession 0000950170-23-073844 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-12-29 | 2023-12-27 | IRON | Bryce Joanne | CFO | M - OptEx | $9.86 | +3,000 | 5,500 | +120% | +$29.6K |
| D | 2023-12-29 | 2023-12-27 | IRON | Bryce Joanne | CFO | M - OptEx | $0.00 | -3,000 | 73.7K | -4% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-12-27 | M | A | 3,000 | $9.86 | 5,500 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2023-12-27 | M | D | 3,000 | $0.00 | 73,745 | D | $9.86 · — to 2031-09-13 | 3,000 Common Stock | (F1) The shares underlying this option vest in 48 equal monthly installments following September 1, 2021, subject to the Reporting Person's continued service on each such vesting date. |